ReMEDy II

Enrolling By Invitation
99 years or below
All
Phase N/A
1 Location

Brief description of study

This study will evaluate the safety and efficacy of DM199 in acute ischemic stroke patients who are not eligible for either tPA or mechanical thrombectomy.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

Updated on 02 Apr 2026. Study ID: 21-1011
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research